SARAH TURGEON DESILETS
MONTREAL,QUEBEC
Summary
- Passionate, ambitious and dedicated physiotherapist with a strong commitment to improving patient outcomes through evidence-based practices and personalized treatment plans.
- Bilingual (spoken and written)
- Member of the OPPQ (Ordre de la Physiothérapie du Québec)
- Results-driven leader with excellent interpersonal skills
Overview
10
10
years of professional experience
1
1
Certification
Work History
Associate Academic Clinical Education Coordinator
MCGILL UNIVERSITY
Montréal , Quebec
2022.01 - Current
- Coordinated and taught responsibilities for four clinical practical courses and two clinical practicum preparatory seminars for students.
- Provided academic counseling to identify student learning needs and support students facing challenges in clinical practical courses
- Provided ongoing professional development for clinical educators at various clinical teaching sites.
- Contributed to the ongoing development of teaching programs at clinical teaching sites.
Faculty Lecturer and Course Coordinator
MCGILL UNIVERSITY
Montréal , Quebec
2020.01 - Current
- Selected innovative teaching methods to deliver course content.
- Evaluated student progress, delivering feedback for individual improvement.
- Improved classroom teaching methods by observing fellow educators and learning new techniques.
- Participated in continuing development and training to bolster professional teaching skills.
Courses:
- PHTH 606 : Introduction to Pediatric Physical Therapy (2020-2022 and 2024)
- POTH 602: Advanced Educational and Management Strategies (2022)
Clinical Evaluator
MCGILL RESEARCH INSTITUTE
Montréal , Quebec
2015.09 - Current
- Roche Pharmaceuticals: Manatee- A Study of RO7204239 in Combination with Risdiplam Treatment in Pediatric Patients with SMA (2023-2024)
- Reveragen Biopharma: A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Activecontrolled Study with Double-Blind Extension to Assess the Efficacy and Safety of Vamorolone in Ambulant Boys with Duchenne Muscular Dystrophy (2019-2020)
- Roche Pharmaceuticals: Ongoing studies on Spinal Muscular Amyotrophy II-III (2018-2020)
- Biogen Pharmaceutical: Ongoing studies on Spinal Muscular Amyotrophy Type I-II (2014-2020)
- Canadian Study of the Common Data Elements of Light Brain Injury in Children (2015-2016)
Physiotherapist
MONTREAL CHILDREN HOSPITAL
Montreal
2014.08 - Current
- Specialized in pediatric physiotherapy for patients with neuromuscular, neonatal, and neurological conditions.
- Guided and mentored master's students in their internship program for physiotherapy
- McGill University Physiotherapy Student Master's Project Supervisor: An Exploration of Assessment Tools Evaluating Children and Young Adults living with Duchenne Muscular Dystrophy - A Scoping Review
Professional Consultant - Spinal Muscular Atrophy
ROCHE CANADA
Toronto
2020.01 - 2023.01
- Assisted in the development and delivery of specialized courses for neuromuscular physiotherapists, focusing specifically on spinal muscular atrophy.
Professional Consultant - Spinal Muscular Atrophy
BIOGEN CANADA
Toronto
2017.11 - 2023.01
- Collaborated in the development and delivery of professional courses for neuromuscular physiotherapists focusing on spinal muscular atrophy.
Guest Lecturer
MCGILL UNIVERSITY
Montréal , Quebec
2015.09 - 2020.01
- POTH 563 : Foundations of Professional Practice - Mentoring Seminars (Current)
- POTH 636 : Physical Therapy in Pediatrics (2016-2020)
- IPEA 500 : Roles in Interprofessional Teams (2015-2016)
- POTH 455 : Neurophysiology (2016)
Education
CERTIFICATE IN HEALTH ADMINISTRATION - PUBLIC HEALTH -
Lausanne University
Switzerland01.2017
MASTER OF SCIENCES (APPLIED) IN PHYSIOTHERAPY -
McGill University
Montreal01.2013
B. SC. REHABILITATION SCIENCE IN PHYSICAL THERAPY -
McGill University
Montreal01.2011
Skills
- Active Listening
- Team Leadership
- Organization and Prioritization
- Critical Thinking
- Interpersonal Relations
Languages
English
Full Professional
French
Native/ Bilingual
Accomplishments
- Finkel & al. (2017). Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. Multicenter, double-blind, sham-controlled, phase 3 trial of nusinersen. ENDEAR Study Group. The New England Journal of Medicine.
- Mercuri & al. (2018). Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy. Multicenter, double-blind, sham-controlled, phase 3 trial of nusinersen. ENDEAR CHERISH Study
Group. The New England Journal of Medicine.
Certification
- Neuro-Developmental Introduction Training (NDT) | Mackay Rehabilitation Center
- Prevention of running injuries | 20 hrs of training with Blaise Dubois
- Quebec Association of Manual Orthopedic Therapy | Clinical integration course 1
- Dynamic Tape Neuroproprioceptive | Completed training
- Red Cross | First Aid & CPR / DEA level C training
Extracurricular Activities
- SMA Academy 2021 | Chair (2021)
- Muscular Dystrophy Canada Clinical Research Grants Reviewer (2022)
- Muscular Dystrophy Canada Advocacy Advisory Committee (2021)
- National Institute of Excellence in Health and Social Services | Current Advisory Committee on Spinal Amyotrophy (2019)
- Annual Steinberg Lecture and Professional Development | Guest Lecturer on: The Role of Physiotherapy in Spinal Muscular Amyotrophy (2019)
- Association Physiothérapie Montréal | Guest Lecturer on: Plagiocephaly and Congenital Torticollis (2019)
- Canadian SMA Summit | Guest Lecturer on: Motor assessment tools and spinal muscular atrophy (2018)
- Sharing clinical cases in rehabilitation for patients with Spinal muscular atrophy – Biogen Canada (2019)
- Muscular Dystrophy Canada | Member of the Organizing Committee of the Canadian Symposium on Diseases Neuromuscular and ALS (2018)
- McGill University Sports Medicine Clinic | Assistant volunteered physiotherapist volunteer to the Athletics team (2010-2013)
- Defi Sportif | Volunteer physiotherapist (2014)
- Fundraising at annual events | Canadian Cancer Society (2010-2014)
Committees
- Réseau Québécois de l'Amyotrophie Spinale (RQAS) | Executive Committee Member (2023- Current)
- Muscular Dystrophy Canada | Advisory committee for the defense of patients' rights (2021- Current)
References
References available upon request.
Timeline
Associate Academic Clinical Education Coordinator
MCGILL UNIVERSITY
2022.01 - Current
Faculty Lecturer and Course Coordinator
MCGILL UNIVERSITY
2020.01 - Current
Professional Consultant - Spinal Muscular Atrophy
ROCHE CANADA
2020.01 - 2023.01
Professional Consultant - Spinal Muscular Atrophy
BIOGEN CANADA
2017.11 - 2023.01
Clinical Evaluator
MCGILL RESEARCH INSTITUTE
2015.09 - Current
Guest Lecturer
MCGILL UNIVERSITY
2015.09 - 2020.01
Physiotherapist
MONTREAL CHILDREN HOSPITAL
2014.08 - Current
CERTIFICATE IN HEALTH ADMINISTRATION - PUBLIC HEALTH -
Lausanne University
MASTER OF SCIENCES (APPLIED) IN PHYSIOTHERAPY -
McGill University
B. SC. REHABILITATION SCIENCE IN PHYSICAL THERAPY -
McGill University
- Neuro-Developmental Introduction Training (NDT) | Mackay Rehabilitation Center
- Prevention of running injuries | 20 hrs of training with Blaise Dubois
- Quebec Association of Manual Orthopedic Therapy | Clinical integration course 1
- Dynamic Tape Neuroproprioceptive | Completed training
- Red Cross | First Aid & CPR / DEA level C training
Similar Profiles
Lu HanLu Han
Teacher Helper at McGill UniversityTeacher Helper at McGill University
Benafsha Bashar DoostBenafsha Bashar Doost
Research Assistant at McGill UniversityResearch Assistant at McGill University
Pablo Emilio Galindo RamírezPablo Emilio Galindo Ramírez
Teaching Assistant at McGill UniversityTeaching Assistant at McGill University